Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Method and composition for hyperthermally treating cells
Instantaneous single click perpetual date mechanism
Systems and related methods of user-guided searching
2,4-disubstituted pyrimidines useful as kinase inhibitors
Disk drive to enable defect margining
Respirator belt having bumper cushion
Delay lines, amplifier systems, transconductance compensating systems and methods of compensating
  Randomly Featured Patents
Flexible-disc drive spindle assembly with brushless DC motor
Apparatus for lifting crops
Deodorizing device of an air conditioning system for automotive vehicles
Bicycle head lamp
High power switching module
Method of producing an endoprosthesis as a joint substitute for knee-joints
Compact nozzle assembly for an inkjet printer
Multi-layer golf ball
Braided occlusion device having repeating expanded volume segments separated by articulation segments